Poland – General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents – Dostawy produktów leczniczych

Part No. 1: Non-pegylated liposomal doxorubicin

Part No. 2: Denosumab

Part No. 3: Abiraterone acetate

Part No. 4: Aprepitant

Part No. 5: Zoledronic acid

Part No. 6: Rituximab

Part No. 7: Azacitidine

Part No. 8: Tretinoin

Part No. 9: Trabectedin

Part No. 10: Mesna

Part No. 11: Peginterferon alfa-2a

Part No. 12: Vinorelbine

Part No. 13: Various medicinal products

Part No. 14: Panitumumab

Part No. 15: Denosumab

Part No. 16: Aflibercept

Part No. 17: Bosutinib

Part No. 18: Paclitaxel in the form of a nano-particle albumin-bound complex